speb/financial-data huggingface dataset:
CVE cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 172000000.00
CVE balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 40000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 40000000.00
CVE income_statement (annual, 2024-12-31) — EBIT: 4720000000.00
CVE income_statement (annual, 2024-12-31) — EBITDA: 9591000000.00
CVE income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 66000000.00
CVE cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -66000000.00
CVE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 262000000.00
CVE balance_sheet (annual, 2024-12-31) — Employee Benefits: 365000000.00
CVE cash_flow (annual, 2024-12-31) — End Cash Position: 3093000000.00
CVE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -3505000000.00
CVE balance_sheet (annual, 2024-12-31) — Finished Goods: 3951000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Finished Goods: 3951000000.00
CVE cash_flow (annual, 2024-12-31) — Free Cash Flow: 4220000000.00
CVE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 12000000.00
CVE income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 119000000.00
CVE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -520000000.00
CVE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2313000000.00
CVE income_statement (annual, 2024-12-31) — General And Administrative Expense: 794000000.00
CVE balance_sheet (annual, 2024-12-31) — Goodwill: 2923000000.00
CVE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2934000000.00
CVE balance_sheet (annual, 2024-12-31) — Gross PPE: 72441000000.00
CVE income_statement (annual, 2024-12-31) — Gross Profit: 12765000000.00
CVE cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 868000000.00
CVE balance_sheet (annual, 2024-12-31) — Income Tax Payable: 396000000.00
CVE income_statement (annual, 2024-12-31) — Interest Expense: 649000000.00
CVE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 649000000.00
CVE income_statement (annual, 2024-12-31) — Interest Income: 170000000.00
CVE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 170000000.00
CVE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 356000000.00
CVE balance_sheet (annual, 2024-12-31) — Interest Payable: 72000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Interest Payable: 72000000.00
CVE balance_sheet (annual, 2024-12-31) — Inventory: 4496000000.00
CVE balance_sheet (annual, 2024-12-31) — Invested Capital: 37105000000.00
CVE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -5126000000.00
CVE balance_sheet (annual, 2024-12-31) — Investments And Advances: 679000000.00
CVE balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 219000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Investments In Other Ventures Under Equity Method: 219000000.00
CVE balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 399000000.00
CVE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CVE balance_sheet (annual, 2024-12-31) — Leases: 592000000.00
CVE balance_sheet (annual, 2024-12-31) — Line Of Credit: 173000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 173000000.00
CVE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2568000000.00
CVE balance_sheet (annual, 2024-12-31) — Long Term Debt: 7342000000.00
CVE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 9910000000.00
CVE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
CVE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -299000000.00
CVE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 618000000.00
CVE balance_sheet (annual, 2024-12-31) — Long Term Provisions: 4654000000.00
CVE balance_sheet (annual, 2024-12-31) — Minority Interest: 15000000.00
CVE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 24000000.00
CVE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1488000000.00
CVE balance_sheet (annual, 2024-12-31) — Net Debt: 4614000000.00
CVE cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 550000000.00
CVE income_statement (annual, 2024-12-31) — Net Income: 3142000000.00
CVE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 3106000000.00
CVE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 3142000000.00
CVE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 3142000000.00
CVE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 3142000000.00
CVE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 3142000000.00
CVE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 3142000000.00
CVE income_statement (annual, 2024-12-31) — Net Interest Income: -514000000.00
CVE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -80000000.00
CVE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -294000000.00
CVE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -299000000.00
CVE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -514000000.00
CVE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -55000000.00
CVE balance_sheet (annual, 2024-12-31) — Net PPE: 41002000000.00
CVE cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: -250000000.00
CVE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 5000000.00
CVE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 26820000000.00
CVE balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 93000000.00
CVE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 1064000000.00
CVE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 4045000000.00
CVE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1064000000.00
CVE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 4045000000.00
CVE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 269000000.00
CVE income_statement (annual, 2024-12-31) — Normalized EBITDA: 10188000000.00
CVE income_statement (annual, 2024-12-31) — Normalized Income: 3602884000.00
CVE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 9235000000.00
CVE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 377000000.00
CVE income_statement (annual, 2024-12-31) — Operating Income: 5061000000.00
CVE income_statement (annual, 2024-12-31) — Operating Revenue: 57726000000.00
CVE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1823038000.00
CVE balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 192000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 192000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2313000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Equity Interest: 12000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 12000000.00
CVE income_statement (annual, 2024-12-31) — Other Gand A: 399000000.00
CVE income_statement (annual, 2024-12-31) — Other Income Expense: -476000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 11000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Investments: 61000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Other Investments: 61000000.00
CVE cash_flow (annual, 2024-12-31) — Other Non Cash Items: -13000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 333000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 434000000.00
CVE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 55000000.00
CVE income_statement (annual, 2024-12-31) — Other Operating Expenses: 6910000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Payable: 110000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Other Payable: 110000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Properties: 4492000000.00
CVE balance_sheet (annual, 2024-12-31) — Other Receivables: 9000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Other Receivables: 9000000.00
CVE balance_sheet (annual, 2024-12-31) — Payables: 6413000000.00
CVE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6495000000.00
CVE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 132000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 132000000.00
CVE balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 26000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 26000000.00
CVE balance_sheet (annual, 2024-12-31) — Preferred Stock: 356000000.00
CVE cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -45000000.00
CVE cash_flow (quarterly, 2024-12-31) — Preferred Stock Dividend Paid: -18000000.00
CVE income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 36000000.00
CVE balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 356000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 356000000.00
CVE cash_flow (annual, 2024-12-31) — Preferred Stock Payments: -250000000.00
CVE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 187000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 187000000.00
CVE income_statement (annual, 2024-12-31) — Pretax Income: 4071000000.00
CVE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 78000000.00
CVE cash_flow (annual, 2024-12-31) — Purchase Of Business: -22000000.00
CVE balance_sheet (annual, 2024-12-31) — Raw Materials: 545000000.00
CVE balance_sheet (quarterly, 2024-12-31) — Raw Materials: 545000000.00
CVE balance_sheet (annual, 2024-12-31) — Receivables: 2658000000.00
CVE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 44961000000.00
CVE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4871000000.00
CVE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -299000000.00
CVE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1738000000.00
CVE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 196000000.00
CVE balance_sheet (annual, 2024-12-31) — Retained Earnings: 10513000000.00
CVE income_statement (annual, 2024-12-31) — Salaries And Wages: 395000000.00
CVE cash_flow (annual, 2024-12-31) — Sale Of Business: 46000000.00
CVE income_statement (annual, 2024-12-31) — Selling General And Administration: 794000000.00
CVE balance_sheet (annual, 2024-12-31) — Share Issued: 1825038000.00
CVE income_statement (annual, 2024-12-31) — Special Income Charges: -77000000.00
CVE cash_flow (annual, 2024-12-31) — Stock Based Compensation: -145000000.00
CVE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 29754000000.00
CVE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 26464000000.00
CVE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -136116000.00
CVE income_statement (annual, 2024-12-31) — Tax Provision: 929000000.00
CVE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
CVE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 231000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Assets: 56539000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Capitalization: 37096000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Debt: 10634000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 29769000000.00
CVE income_statement (annual, 2024-12-31) — Total Expenses: 52665000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 26770000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 46105000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 19408000000.00
CVE income_statement (annual, 2024-12-31) — Total Other Finance Cost: 35000000.00
CVE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 396000000.00
CVE income_statement (annual, 2024-12-31) — Total Unusual Items: -597000000.00
CVE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -597000000.00
CVE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 2000000.00
CVE balance_sheet (annual, 2024-12-31) — Treasury Stock: 43000000.00
CVE balance_sheet (annual, 2024-12-31) — Working Capital: 3072000000.00
CVE income_statement (quarterly, 2025-03-31) — +Operating Expense: 1826000000.00
CVE income_statement (quarterly, 2025-03-31) — +Total Revenue: 14205000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5948000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2711000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -32712000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 843000000.00
CVE income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 1000000.00
CVE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1821325000.00
CVE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.47
CVE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3093000000.00
CVE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1229000000.00
CVE cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1229000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2925000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 15856000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2768000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2768000000.00
CVE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -333000000.00
CVE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -294000000.00
CVE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1348000000.00
CVE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1315000000.00
CVE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -861000000.00
CVE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -327000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Common Stock: 15640000000.00
CVE cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -327000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 29816000000.00
CVE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -62000000.00
CVE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 11095000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Current Assets: 10103000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 381000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Current Debt: 515000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 896000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 6910000000.00
CVE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -66000000.00
CVE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -66000000.00
CVE cash_flow (quarterly, 2025-03-31) — Depreciation: 1314000000.00
CVE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1314000000.00
CVE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1314000000.00
CVE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1831265000.00
CVE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.47
CVE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 854000000.00
CVE cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 25000000.00
CVE income_statement (quarterly, 2025-03-31) — EBIT: 1293000000.00
CVE income_statement (quarterly, 2025-03-31) — EBITDA: 2607000000.00
CVE income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -7000000.00
CVE cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 7000000.00
CVE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 2000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 337000000.00
CVE cash_flow (quarterly, 2025-03-31) — End Cash Position: 2768000000.00
CVE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -294000000.00
CVE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 86000000.00
CVE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 23000000.00
CVE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
CVE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -15000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2303000000.00
CVE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 197000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Goodwill: 2923000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2923000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 73807000000.00
CVE income_statement (quarterly, 2025-03-31) — Gross Profit: 3110000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 66000000.00
CVE income_statement (quarterly, 2025-03-31) — Interest Expense: 163000000.00
CVE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 163000000.00
CVE income_statement (quarterly, 2025-03-31) — Interest Income: 33000000.00
CVE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 33000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Inventory: 4316000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 37663000000.00
CVE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1348000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 362000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 362000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Leases: 597000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 323000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2544000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 7332000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 9876000000.00
CVE cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -95000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 362000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 4706000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 15000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -100000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -62000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Net Debt: 5079000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 19000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Income: 859000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 853000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 859000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 859000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 859000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 859000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 859000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Interest Income: -136000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 4000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 55000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -95000000.00
CVE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -136000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 300000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -23000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Net PPE: 41095000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: -200000000.00
CVE cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 150000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 27109000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 25000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1188000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4047000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1188000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4047000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 270000000.00
CVE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 2624000000.00
CVE income_statement (quarterly, 2025-03-31) — Normalized Income: 871923008.85
CVE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1315000000.00
CVE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 49000000.00
CVE income_statement (quarterly, 2025-03-31) — Operating Income: 1284000000.00
CVE income_statement (quarterly, 2025-03-31) — Operating Revenue: 14205000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1821642000.00
CVE balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 192000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2303000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 11000000.00
CVE income_statement (quarterly, 2025-03-31) — Other Gand A: 197000000.00
CVE income_statement (quarterly, 2025-03-31) — Other Income Expense: -18000000.00
CVE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -12000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 684000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 457000000.00
CVE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 6000000.00
CVE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1629000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Other Properties: 4570000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Payables: 6014000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6014000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 216000000.00
CVE cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -6000000.00
CVE income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 6000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 216000000.00
CVE cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: -200000000.00
CVE income_statement (quarterly, 2025-03-31) — Pretax Income: 1130000000.00
CVE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -54000000.00
CVE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -100000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Receivables: 3019000000.00
CVE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 11095000000.00
CVE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1314000000.00
CVE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -95000000.00
CVE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -262000000.00
CVE income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 2000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 11039000000.00
CVE cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CVE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 197000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Share Issued: 1822658000.00
CVE income_statement (quarterly, 2025-03-31) — Special Income Charges: -2000000.00
CVE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 30032000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 26893000000.00
CVE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -4076991.15
CVE income_statement (quarterly, 2025-03-31) — Tax Provision: 271000000.00
CVE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CVE balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 308000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Assets: 56380000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 37364000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Debt: 10772000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 30047000000.00
CVE income_statement (quarterly, 2025-03-31) — Total Expenses: 12921000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 26333000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 46277000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 19423000000.00
CVE income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 6000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 66000000.00
CVE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -17000000.00
CVE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -17000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 1016000.00
CVE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 20000000.00
CVE balance_sheet (quarterly, 2025-03-31) — Working Capital: 3193000000.00
CVE income_statement (quarterly, 2025-06-30) — +Operating Expense: 1904000000.00
CVE income_statement (quarterly, 2025-06-30) — +Total Revenue: 12319000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 6218000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2916000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -33383000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 646000000.00
CVE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1810639000.00
CVE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2768000000.00
CVE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1164000000.00
CVE cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1164000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2989000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 15612000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2563000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2563000000.00
CVE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -368000000.00
CVE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1078000000.00
CVE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1375000000.00
CVE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2374000000.00
CVE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 923000000.00
CVE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -79000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Common Stock: 15499000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 29289000000.00
CVE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -316000000.00
CVE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 9725000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Current Assets: 9456000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 371000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Current Debt: 438000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 809000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7142000000.00
CVE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -127000000.00
CVE cash_flow (quarterly, 2025-06-30) — Deferred Tax: -127000000.00
CVE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1184000000.00
CVE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 847000000.00
CVE cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 58000000.00
CVE income_statement (quarterly, 2025-06-30) — EBIT: 1170000000.00
CVE income_statement (quarterly, 2025-06-30) — EBITDA: 2354000000.00
CVE income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 43000000.00
CVE cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -43000000.00
CVE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -126000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 337000000.00
CVE cash_flow (quarterly, 2025-06-30) — End Cash Position: 2563000000.00
CVE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1078000000.00
CVE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1210000000.00
CVE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -69000000.00
CVE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 3000000.00
CVE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 445000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1645000000.00
CVE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 153000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Goodwill: 2923000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2923000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 74521000000.00
CVE income_statement (quarterly, 2025-06-30) — Gross Profit: 2594000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 115000000.00
CVE income_statement (quarterly, 2025-06-30) — Interest Expense: 154000000.00
CVE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 154000000.00
CVE income_statement (quarterly, 2025-06-30) — Interest Income: 50000000.00
CVE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 50000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Inventory: 3917000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 36786000000.00
CVE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1375000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 338000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 338000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Leases: 597000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 256000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2618000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 7059000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9677000000.00
CVE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -94000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 338000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 4783000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 15000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -116000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -316000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Net Debt: 4934000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -420000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Income: 851000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 847000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 851000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 851000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 851000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 851000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 851000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Interest Income: -114000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -17000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -178000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -94000000.00
CVE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -114000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -72000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -78000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Net PPE: 41138000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: -150000000.00
CVE cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -84000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 26479000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 25000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1215000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 4001000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1215000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 4001000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 262000000.00
CVE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1983000000.00
CVE income_statement (quarterly, 2025-06-30) — Normalized Income: 540250984.25
CVE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2374000000.00
CVE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -535000000.00
CVE income_statement (quarterly, 2025-06-30) — Operating Income: 690000000.00
CVE income_statement (quarterly, 2025-06-30) — Operating Revenue: 12319000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1804163000.00
CVE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 182000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1645000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 11000000.00
CVE income_statement (quarterly, 2025-06-30) — Other Gand A: 153000000.00
CVE income_statement (quarterly, 2025-06-30) — Other Income Expense: 440000000.00
CVE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 8000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 725000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 463000000.00
CVE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 26000000.00
CVE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1751000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Other Properties: 4643000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Payables: 6333000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 6333000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 113000000.00
CVE income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 4000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 113000000.00
CVE cash_flow (quarterly, 2025-06-30) — Preferred Stock Payments: -150000000.00
CVE income_statement (quarterly, 2025-06-30) — Pretax Income: 1016000000.00
CVE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 6000000.00
CVE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -129000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Receivables: 2976000000.00
CVE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 9725000000.00
CVE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1184000000.00
CVE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -94000000.00
CVE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -466000000.00
CVE income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 77000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 11522000000.00
CVE cash_flow (quarterly, 2025-06-30) — Sale Of Business: 13000000.00
CVE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 153000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Share Issued: 1805942000.00
CVE income_statement (quarterly, 2025-06-30) — Special Income Charges: -74000000.00
CVE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 12000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 29402000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 26366000000.00
CVE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 60250984.25
CVE income_statement (quarterly, 2025-06-30) — Tax Provision: 165000000.00
CVE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.16
CVE balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 60000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Assets: 55820000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 36461000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Debt: 10486000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 29417000000.00
CVE income_statement (quarterly, 2025-06-30) — Total Expenses: 11629000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 26403000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 46364000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 19261000000.00
CVE income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 10000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 115000000.00
CVE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 371000000.00
CVE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 371000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1779000.00
CVE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 34000000.00
CVE balance_sheet (quarterly, 2025-06-30) — Working Capital: 2314000000.00
CVE income_statement (quarterly, 2025-09-30) — +Operating Expense: 1814000000.00
CVE income_statement (quarterly, 2025-09-30) — +Total Revenue: 13195000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5216000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4688000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -30121000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 296000000.00
CVE income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
CVE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1788901000.00
CVE income_statement (quarterly, 2025-09-30) — Basic EPS: 0.72
CVE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2563000000.00
CVE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1154000000.00
CVE cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1154000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2872000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 15275000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1901000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1901000000.00
CVE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -356000000.00
CVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1519000000.00
CVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1316000000.00
CVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2131000000.00
CVE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -241000000.00
CVE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -704000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Common Stock: 15162000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 28261000000.00
CVE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -939000000.00
CVE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 9868000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Current Assets: 9769000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 342000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 342000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5651000000.00
CVE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -327000000.00
CVE cash_flow (quarterly, 2025-09-30) — Deferred Tax: -327000000.00
CVE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1322000000.00
CVE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1792780000.00
CVE income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.72
CVE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1284000000.00
CVE cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 27000000.00
CVE income_statement (quarterly, 2025-09-30) — EBIT: 1455000000.00
CVE income_statement (quarterly, 2025-09-30) — EBITDA: 2777000000.00
CVE income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 9000000.00
CVE cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -9000000.00
CVE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 42000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 381000000.00
CVE cash_flow (quarterly, 2025-09-30) — End Cash Position: 1901000000.00
CVE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1519000000.00
CVE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 977000000.00
CVE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -19000000.00
CVE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 106000000.00
CVE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -155000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 619000000.00
CVE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 220000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Goodwill: 2923000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2923000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 68437000000.00
CVE income_statement (quarterly, 2025-09-30) — Gross Profit: 3327000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 93000000.00
CVE income_statement (quarterly, 2025-09-30) — Interest Expense: 158000000.00
CVE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 158000000.00
CVE income_statement (quarterly, 2025-09-30) — Interest Income: 28000000.00
CVE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 28000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Inventory: 3126000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 35417000000.00
CVE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1316000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 321000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 321000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Leases: 597000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
CVE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2530000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 7156000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 9686000000.00
CVE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -272000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 321000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 5033000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 15000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -7000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -939000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Net Debt: 5255000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 157000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Income: 1286000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1284000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1286000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1286000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1286000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1286000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1286000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Interest Income: -154000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 4000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -186000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -272000000.00
CVE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -154000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -45000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -159000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Net PPE: 38316000000.00
CVE cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
CVE cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 86000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 25451000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 25000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1516000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3949000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1516000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3949000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 264000000.00
CVE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2870000000.00
CVE income_statement (quarterly, 2025-09-30) — Normalized Income: 1378211256.75
CVE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 2131000000.00
CVE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 23000000.00
CVE income_statement (quarterly, 2025-09-30) — Operating Income: 1513000000.00
CVE income_statement (quarterly, 2025-09-30) — Operating Revenue: 13195000000.00
CVE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1763551000.00